Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist
about
Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2The human prostanoid DP receptor stimulates mucin secretion in LS174T cellsProstaglandin D2 and reproductionPharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptorPharmacology and autoradiography of human DP prostanoid receptors using [(3)H]-BWA868C, a DP receptor-selective antagonist radioligandThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsProstaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old miceInverse agonist and pharmacochaperone properties of MK-0524 on the prostanoid DP1 receptorPPAR and immune system--what do we know?Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists.Physiology and pathophysiology of prostanoid receptors.GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist.Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2.Regulation of human penile smooth muscle tone by prostanoid receptors.The cyclo-oxygenase-dependent regulation of rabbit vein contraction: evidence for a prostaglandin E2-mediated relaxation.15-deoxy-Delta12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells.Dynamical modelling of prostaglandin signalling in platelets reveals individual receptor contributions and feedback properties.
P2860
Q24290855-F068613F-1291-44AD-B2A7-C309C0B3F2ABQ24674203-4A44B95D-5243-4F17-8C65-1F379A182B03Q28216393-FCBDDA64-32A2-4EB9-9F2A-AE8F117F7254Q28344632-73E2DE5C-BEB1-4352-AB46-2DAD25DA3278Q28344925-3A3AADB9-23F8-4A0E-8E8C-B26339FF351EQ30486707-E7EB141D-A77A-49E8-B9B5-9ABD0F6D0DF8Q34080404-3D118DFC-DC91-4FFF-BC77-D6CBD9648FA3Q34770179-6352FAF1-0F40-4F03-B9BA-175A518E588EQ34913467-F9515334-1DF0-406F-8D25-F8729F4E5262Q35028755-A1EA69DF-0D61-431D-B538-C1460F04440FQ37383933-04106554-B8A8-4E52-9B61-D65B246CB652Q40294227-45DAE53C-6F15-4334-9765-6C7029011159Q40685661-B6BDC01B-4551-4A7A-8639-41101E50B5BCQ42261833-24158C9E-C7C4-43D9-8612-B74BFFF1515DQ43188114-20335CB8-9C88-4573-A8BA-3AC6426F8FEBQ46958393-6E923459-A790-4524-AC74-1FDC241D89D9Q47889142-2CF58A57-9A85-4696-8AC1-98B71137B5BB
P2860
Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Characterization of the recomb ...... , a novel selective DP agonist
@ast
Characterization of the recomb ...... , a novel selective DP agonist
@en
Characterization of the recomb ...... , a novel selective DP agonist
@nl
type
label
Characterization of the recomb ...... , a novel selective DP agonist
@ast
Characterization of the recomb ...... , a novel selective DP agonist
@en
Characterization of the recomb ...... , a novel selective DP agonist
@nl
prefLabel
Characterization of the recomb ...... , a novel selective DP agonist
@ast
Characterization of the recomb ...... , a novel selective DP agonist
@en
Characterization of the recomb ...... , a novel selective DP agonist
@nl
P2093
P2860
P356
P1476
Characterization of the recomb ...... , a novel selective DP agonist
@en
P2093
A W Ford-Hutchinson
D H Wright
K M Metters
M Abramovitz
P2860
P304
P356
10.1038/SJ.BJP.0701708
P407
P577
1998-04-01T00:00:00Z